The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2012 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2012 AAPM Annual Meeting « Back

    271

    Trends in Nonmedical Use of Nucynta by College Students

    Richard Dart, MD, richard.dart@rmpdc.org1, Edgar H. Adams, ScD2, Becki Bucher-Bartelson, PhD1, Gary M. Baker, PharmD3, Janet K Pitner, PharmD MBA BCPS CGP4, Gary Vorsanger, MD PhD5, (1) Rocky Mountain Poison and Drug Center, Denver, Colorado, (2) Covance, Princeton, New Jersey, (3) Janssen Scientific Affairs, LLC, Reading, Massachusetts, (4) Janssen Scientific Affairs, LLC, Charleston, South Carolina, (5) Janssen Scientific Affairs, LLC, Raritan, New Jersey

    Introduction/Statement of the Problem: Prescription opioid analgesics play an important role in the management of moderate to severe pain. An unintended consequence of these agents is nonmedical use. In 2008, the prevalence of nonmedical use of pain relievers among persons aged 12 or older was second only to marijuana in the U.S.1 We describe the rates and methods of nonmedical use of tapentadol immediate release [Nucynta®, CII] among college students following FDA approval in 2009. Materials and Methods: The RADARS® System2 College Survey Program is an online questionnaire collecting data from approximately 2000 self-identified college-aged students throughout the United States administered during the spring, summer, and fall terms. Responses were analyzed for trends in the rate and method of nonmedical use of tapentadol compared with other opioid analgesics from June 2009 through March 2011. Results: Nonmedical use of tapentadol was highest in 4Q2009 (0.66 per 1,000 people who filled a prescription) and significantly decreased in the four subsequent survey periods (p≤0.001). Similarly, nonmedical use per 100,000 population rate was highest in 4Q2009 (0.013 per 100,000 population) and decreased, although not significantly to 0.004 in 1Q2011 (p = 0.22). The primary method of nonmedical use of tapentadol among college students is oral/transmucosal (78%) followed by inhalation and injection. Conclusion: Since launch, rates of nonmedical use of Nucynta by college students were low and are decreasing over time. The initial levels of reported nonmedical use may represent a brief period of experimentation after introduction. References: 1)Substance Abuse and Mental Health Services Administration. (2010). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. http://www.oas.samhsa.gov/NSDUH/2k9NSDUH/2k9ResultsP.pdf 2)RADARS System. http://radars.org/

    Funding: N/A

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In